Gamunex-c 20 gram/200 ML vial 200ML
Ended Awarded
- Contract number
- SPE2DR26F7WNX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,772
Award facts
- Contract value 100% obligated
- $44,772.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Gamunex-C 20 gram/200 mL vials valued at $44,772.48 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 8, 2025, and performance to be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. Gamunex-C is an intravenous immunoglobulin therapy used for treating immunodeficiency disorders and other immune-related conditions, representing critical pharmaceutical inventory for military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999, running through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply military healthcare systems worldwide, with this specific delivery order exemplifying the company's role in fulfilling critical biopharmaceutical requirements for Defense Department medical operations.
Quick answers
Who was awarded contract SPE2DR26F7WNX?
SPE2DR26F7WNX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F7WNX worth?
The government has obligated $44,772 on SPE2DR26F7WNX.
Is contract SPE2DR26F7WNX an order under another contract?
Yes. SPE2DR26F7WNX is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WNX competed?
The extent of competition for SPE2DR26F7WNX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award